MDMA
Minneapolis Mayor Signs Order Making Psychedelics ‘Lowest Law Enforcement Priority’
The mayor of Minneapolis signed an executive order making the criminalization of psychedelics the city’s lowest law enforcement priority.
The post Minneapolis…
Minneapolis, Minnesota has joined cities like Detroit, Washington, D.C., Seattle and San Francisco in decriminalizing psychedelics.
On Friday, the mayor of Minneapolis signed an executive order making the criminalization of psychedelics the city’s lowest law enforcement priority.
“The investigation and arrest of persons for planting, cultivating, purchasing, transporting, distributing, engaging in practices with, or possessing Entheogenic Plants or plant compounds which are on the federal Schedule 1 list shall be the lowest law enforcement priority for the City of Minneapolis.”
The order effectively decriminalizes psychedelics and also prevents local resources from being used to help state or federal against psychedelics.
“Unless required by law, City resources shall not knowingly be used in any investigation, detention, or arrest arising out of alleged violations of state and federal law for engaging in the above-referenced activities…”
Criminalizing psychedelic use takes resources away from violent crime without improving public health. My executive order makes it a lowest-level enforcement priority. https://t.co/9O6dZ2ZB1l
— Jacob Frey (@Jacob_Frey) July 21, 2023
According to local reporting, LSD, ketamine and MDMA are not included in the order and would remain a priority target of Minneapolis law enforcement. The order also excludes peyote “in order to respect and protect access to these sacred plant medicines of the Native America Church.”
“Regardless of the stigma attached, when you look at the science behind the benefits of entheogens, it all points in one direction…Experts are telling us that these plants help people, and that’s the business we should be in—helping people.”
The post Minneapolis Mayor Signs Order Making Psychedelics ‘Lowest Law Enforcement Priority’ appeared first on Microdose.
peyote mdma lsd ketamine psychedelic-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Psychedelics1 week ago
Algernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Law & Regulation1 week ago
Tryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week ago
Passover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week ago
atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week ago
Psilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment